Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 266.25 -2.7 (-1%) Market Cap: 34.34 Bil Enterprise Value: 33.21 Bil PE Ratio: 0 PB Ratio: 1,065.00 GF Score: 78/100

Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 18, 2021 / 02:30PM GMT
Release Date Price: $135.15 (-0.54%)
Michael W. Bonney
Alnylam Pharmaceuticals, Inc. - Independent Chairman

Good morning or good afternoon, depending on your time zone, and thank you for your participation today.

I'd now like to call to order the 2021 Annual Meeting of Stockholders of Alnylam Pharmaceuticals, Inc., which is being held virtually via the Internet. I am Michael Bonney, Chair of the Board of Directors of the company. I would like to introduce the other directors who are with us today for this Annual Meeting: Dennis Ausiello; Olivier Brandicourt; Marsha Fanucci; Margaret Hamburg; John Maraganore, who is the company's Chief Executive Officer; Steve Paul; David Pyott; Colleen Reitan; Amy Schulman; and Phil Sharp, constituting all of the members of our Board.

Also with us today are several members of the company's senior management and Investor Relations teams, including Yvonne Greenstreet, President and Chief Operating Officer; Akshay Vaishnaw, President, Research and Development; Pushkal Garg, Chief Medical Officer; Laurie Keating, Chief Legal Officer and Secretary; Jeff Poulton, Chief Financial Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot